A little over 50 years ago, my father had a heart attack. Hewas driven to the hospital by friends after having "indigestion"for 2 days. He spent 2 weeks as an inpatient on an unmonitoredrehabilitation ward and was treated principally with warfarinand digitalis. He was lucky and survived, but in that era, morethan 20% of patients with an acute myocardial infarction died.Fast-forward to today, when public education about early recognitionof symptoms, emergency transport, monitored coronary care units,and early reperfusion by means of primary percutaneous coronaryintervention (PCI) have markedly reduced mortality from acute. . . [Full Text of this Article]
Source Information
From the Virginia Commonwealth University Pauley Heart Center, Medical College of Virginia Hospitals, Virginia Commonwealth University, Richmond.
This article has been cited by other articles:
Steg, P. G., Ducrocq, G.
(2008). Devices to protect against embolization during primary angioplasty for ST-segment elevation myocardial infarction: the good, the bad and the ugly. Eur Heart J
29: 2953-2954
[Full Text]
Abbate, A., Kontos, M. C., Biondi-Zoccai, G. G.L.
(2008). No-reflow: the next challenge in treatment of ST-elevation acute myocardial infarction. Eur Heart J
29: 1795-1797
[Full Text]
(2008). Does Thrombus Aspiration Improve Outcomes of Primary Percutaneous Coronary Intervention?. Journal Watch Cardiology
2008: 1-1
[Full Text]